1-2 of 2
Lijuan Deng, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma

Zhitao Ying, MD PhD, Wen Wang, MD, Xiaopei Wang, MD, Wen Zheng, MD, Ningjing Lin, MD PhD, Meifeng Tu, MD PhD, Yan Xie, MD PhD, Lingyan Ping, MD PhD, Chen Zhang, MD PhD, Weiping Liu, MD PhD, Lijuan Deng, MD PhD, Ming Hao, Su Yang, Yan Zhou, BSc, James Li, Yuqin Song, MD PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5388.
https://doi.org/10.1182/blood-2018-99-114527
Published: 2018
Journal Articles

Phase I Study of First-in-Class Oral Triplet Therapy DTRM-555 in Relapsed/Refractory Lymphoma Patients through Fixed-Dose Combination and Synthetic Lethality

Scott F Huntington, MD MPH, Stephen J. Schuster, MD, Wei He, PhD, Tong Shen, PhD, Heather Walker, MPH, CCRP, Laura Leary, Kylie Boyhen, Jennifer Gill, CRNP, Elizabeth T Chatburn, BS, Kaitlin Kennard, RN, BSN, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, David L. Porter, MD, Ellen Napier, NP, Mitchell E. Hughes, PharmD, Tanya Latorre, RN, Kristy Walsh, BS, Colleen Dorsey, BSN, RN, Jakub Svoboda, MD, Victoria Addis, MD, Barry Douglas Anderson, MD PhD, Emily Leblond, Yuqin Song, MD PhD, Jun Zhu, MD PhD, Lijuan Deng, MD PhD, Danielle M. Brander, MD, Wei Ding, MD PhD, Allison C. Rosenthal, DO, Han Tun, MD, Anthony R. Mato, MD MSCE
Journal: Blood
Blood (2018) 132 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2018-99-112944
Published: 2018